Dr Srinivas Akkaraju

Biography

Srinivas Akkaraju is a former General Partner of Sofinnova Ventures. Prior to Sofinnova, Srini was a Managing Director of New Leaf Venture Partners, and prior to that, a Founding Managing Director at Panorama Capital, LLC., a prior to that, a Partner with J.P. Morgan Partners. Before his investment career, he was in Business and Corporate Development at Genentech, Inc. (now a wholly owned member of The Roche Group), a biotechnology company, most recently as Senior Manager. Dr Akkaraju currently serves as a Director of Intercept Pharmaceuticals, Inc., Seattle Genetics, Versartis Inc., and aTyr Pharma, Inc. Previously, Dr. Akkaraju served as a director on the boards of ZS Pharma, Inc., Eyetech Pharmaceuticals, Inc., Synageva Biopharma Corp., Barrier Therapeutics, Inc., and Amarin Corporation plc. Srinivas joined the Board February 2016.

Research Interest

medical sciences